top glp-1 dual agonist competitors to zepbound vs Wegovy A Clinician's Evidence-Based Comparison Use of the dual GIP/GLP-1

It was not microdosing

Abstract Aims/hypothesis Metformin lowers postprandial glycaemic excursions in individuals with type 2 diabetes by modulating gastrointestinal function, including the stimulation of glucagon-like peptide-1 (GLP-1)

The field is not ready for practice-changing recommendationsbut the curiosity is warranted , and the possibilities are worth watching

A review in Gut Microbes described it as a "butyrate-producing human gut symbiont" with documented benefits for intestinal barrier integrity, immune modulation, and metabolic signaling

And this peptide in Gila monster spit instead of disappearing in minutes like GLP-1, it can last for hours

The STEP 1 extension found that the cardiometabolic improvements seen during treatment including blood sugar, blood pressure and cholesterol largely reverted toward baseline within a year of stopping